ArticlePsychiatry investigation2016

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study.

Young Sup Woo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.